CDMO: Avid Bioservices, Inc.
About
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Current Value
$12.191 Year Return
Current Value
$12.191 Year Return
Key Details
Market Cap
$779.62M
P/E Ratio
-5.37
1Y Stock Return
122.04%
1Y Revenue Growth
-5.28%
Dividend Yield
0.00%
Price to Book
13.3
Strategies that include CDMO
Stock's related to CDMO
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GRAL | 44.91% | $459.22M | -13.00% | 0.00% |
| BLFS | 42.92% | $1.04B | +64.64% | 0.00% |
| CIEN | 41.08% | $9.69B | +47.41% | 0.00% |
| MEI | 40.54% | $326.37M | -60.53% | 6.06% |
| VIAV | 39.87% | $2.16B | +23.26% | 0.00% |
| NVEE | 38.61% | $1.45B | -9.73% | 0.00% |
| PGEN | 37.58% | $228.91M | -28.00% | 0.00% |
| TPVG | 37.48% | $272.08M | - | 18.82% |
| CYRX | 37.25% | $342.80M | -48.82% | 0.00% |
| FARO | 37.05% | $486.17M | +40.51% | 0.00% |
| TTGT | 36.74% | $892.25M | +1.87% | 0.00% |
| KRNT | 36.66% | $1.48B | +73.34% | 0.00% |
| EVGO | 36.50% | $625.86M | +97.63% | 0.00% |
| ALNT | 35.87% | $419.62M | -4.92% | 0.36% |
| ADTN | 34.89% | $627.65M | +47.76% | 0.00% |
| MGTX | 34.85% | $467.36M | +9.12% | 0.00% |
| VRDN | 34.80% | $1.60B | +28.92% | 0.00% |
| BLNK | 34.70% | $156.82M | -57.53% | 0.00% |
| HDSN | 33.91% | $260.34M | -54.39% | 0.00% |
| CERS | 33.66% | $312.00M | -0.59% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEST | 0.01% | $31.65M | +3.88% | 0.00% |
| IBKR | -0.03% | $20.20B | +131.83% | 0.37% |
| HIHO | -0.05% | $8.63M | 0.00% | 6.12% |
| WTW | 0.07% | $30.98B | +26.60% | 1.13% |
| FSK | 0.07% | - | - | 11.89% |
| BCAN | 0.09% | $72.87M | -99.75% | 0.00% |
| VNOM | -0.13% | $5.48B | +79.62% | 3.35% |
| TGS | 0.15% | $1.97B | +116.04% | 0.00% |
| WLY | -0.16% | $2.71B | +65.47% | 2.83% |
| CLLS | -0.16% | $141.30M | -30.99% | 0.00% |
| COST | -0.36% | $412.13B | +62.81% | 0.49% |
| AKAM | 0.37% | $13.12B | -22.78% | 0.00% |
| FENG | 0.54% | $13.37M | +96.77% | 0.00% |
| LMT | -0.54% | $126.40B | +18.99% | 2.36% |
| KEP | 0.56% | $11.16B | +25.58% | 0.00% |
| DECK | 0.57% | $26.78B | +66.79% | 0.00% |
| RSG | 0.58% | $66.05B | +31.79% | 1.04% |
| SUPV | 0.58% | $881.60M | +339.37% | 1.51% |
| PBR | -0.60% | $52.88B | -8.22% | 5.68% |
| SYPR | -0.62% | $32.23M | -26.32% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| IMRN | -37.06% | $10.31M | -5.04% | 0.00% |
| AGR | -19.16% | $13.92B | +15.51% | 4.90% |
| MCK | -15.28% | $78.15B | +35.51% | 0.42% |
| ACGL | -12.57% | $36.00B | +16.84% | 0.00% |
| KR | -10.19% | $42.03B | +35.08% | 2.11% |
| CCJ | -9.48% | $25.01B | +28.34% | 0.15% |
| NVO | -9.15% | $342.62B | -0.15% | 1.40% |
| RNR | -8.86% | $13.74B | +23.09% | 0.58% |
| LPTH | -8.22% | $62.27M | +33.05% | 0.00% |
| HUSA | -7.96% | $16.69M | -11.56% | 0.00% |
| LPLA | -7.70% | $23.55B | +38.13% | 0.38% |
| BYRN | -7.62% | $479.70M | +295.19% | 0.00% |
| NXE | -7.57% | $4.79B | +29.91% | 0.00% |
| EG | -7.48% | $15.92B | -8.98% | 2.02% |
| PGR | -7.46% | $149.10B | +57.29% | 0.45% |
| MBI | -6.99% | $335.78M | +105.79% | 0.00% |
| TCTM | -6.81% | $8.10M | -42.99% | 0.00% |
| ALL | -6.37% | $52.06B | +45.67% | 1.85% |
| KB | -6.09% | $24.84B | +59.60% | 4.17% |
| QNRX | -5.80% | $3.20M | -85.07% | 0.00% |
ETF's related to CDMO
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 46.51% | $70.59M | 0.5% |
| XBI | 45.13% | $6.58B | 0.35% |
| ARKG | 43.70% | $1.13B | 0.75% |
| PBE | 43.65% | $258.53M | 0.58% |
| PSC | 42.41% | $702.17M | 0.38% |
| PTH | 42.05% | $143.31M | 0.6% |
| IBB | 41.61% | $6.66B | 0.45% |
| FSMD | 41.42% | $583.89M | 0.15% |
| EES | 40.88% | $668.71M | 0.38% |
| DFAT | 40.79% | $11.16B | 0.28% |
| IWO | 40.55% | $12.56B | 0.24% |
| FBT | 40.36% | $1.11B | 0.56% |
| VTWO | 40.34% | $12.38B | 0.1% |
| SLYV | 40.32% | $4.16B | 0.15% |
| IWC | 40.31% | $933.99M | 0.6% |
| IWM | 40.10% | $75.73B | 0.19% |
| NUSC | 39.94% | $1.27B | 0.31% |
| ESML | 39.94% | $1.90B | 0.17% |
| PRFZ | 39.85% | $2.65B | 0.39% |
| VBK | 39.75% | $19.31B | 0.07% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| USCI | -0.09% | $185.47M | 1.07% |
| FLTR | -0.17% | $1.79B | 0.14% |
| URA | 0.17% | $3.55B | 0.69% |
| HDRO | -0.19% | $164.26M | 0.3% |
| JUCY | -0.31% | $324.29M | 0.6% |
| JBBB | 0.58% | $1.26B | 0.49% |
| GBIL | 0.65% | $5.60B | 0.12% |
| URNJ | 0.74% | $283.55M | 0.8% |
| SOYB | -0.97% | $27.32M | 0.22% |
| IBHD | -1.03% | $327.80M | 0.35% |
| ICLO | 1.13% | $209.30M | 0.2% |
| DUSB | -1.18% | $797.63M | 0.15% |
| CANE | -1.19% | $17.72M | 0.29% |
| DBMF | -1.30% | $1.02B | 0.85% |
| XBIL | 1.47% | $637.70M | 0.15% |
| MINT | -1.89% | $11.62B | 0.35% |
| SGOV | 2.00% | $27.53B | 0.09% |
| BILZ | 2.02% | $563.02M | 0.14% |
| HIGH | 2.06% | $302.78M | 0.51% |
| WEAT | 2.13% | $120.27M | 0.28% |
News
Finnhub
Ampersand Capital Partners and GHO Capital Partners will acquire Avid Bioservices for approximately $1.1 billion, according to a news release. Avid , formed in 2002 and based in Orange County,...
Yahoo
We came across a bullish thesis on Avid Bioservices, Inc. (CDMO) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on CDMO. Avid Bioservices, Inc. (CDMO)’s share was trading at $12.20 as of Nov 13th. CDMO’s trailing and forward P/E were 9.41 and 88.50 respectively according to Yahoo Finance. Avid Bioservices, Inc., a […]
Finnhub
On November 14, 2024, Punch & Associates Investment Management, Inc. announced its intention to vote AGAINST the proposed acquisition of Avid Bioservices, Inc. by GHO Capital and Ampersand Capital....
SeekingAlpha
We are bullish on Avid's potential take-private deal by Ampersand and GHO, predicting value creation and optimistic about 1Q25 closing. Read more here.
Yahoo
Avid Bioservices ( (CDMO) ) just unveiled an announcement. Avid Bioservices, a biologics contract development and manufacturing organization, is set to be acquired by GHO Capital Partners and Ampersand Capital Partners in a $1.1 billion all-cash transaction. Shareholders will receive $12.50 per share, representing a premium to recent trading prices. The merger is expected to close in early 2025, subject to customary conditions and approvals. This acquisition aims to leverage the expertise and ca
Finnhub
Ademi LLP is investigating Avid for possible breaches of fiduciary duty and other violations of law in its transaction with GHO and Ampersand.Click here to learn how to join our investigation and...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.